Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab (Exclusively Infusion Solution Concentrate), Atc L04Ac07 For The Period December 1St, 2025 - November 30Th, 2027